Integrating Telehealth to Advance Lung Cancer Screening

Launched by ABRAMSON CANCER CENTER AT PENN MEDICINE · Oct 10, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Integrating Telehealth to Advance Lung Cancer Screening," is investigating how using telehealth—virtual health services—can help people better understand and decide on lung cancer screening options. The researchers want to see if reaching out to patients through phone calls and messages can lead to more people completing visits where they can discuss lung cancer screening with a healthcare provider. They are particularly interested in whether these telehealth methods work equally well for different racial and gender groups.

To participate in this study, you need to be between 50 and 80 years old and have a history of smoking, either currently or in the past. Importantly, you should not have had lung cancer or undergone lung cancer screening in the last two years. If you join the trial, you can expect to receive an invitation for a virtual visit, where you'll have a chance to talk about lung cancer screening options. If you don’t respond right away, you may receive a friendly reminder to help you complete the visit. This study is currently recruiting participants, and they aim to make lung cancer screening more accessible for everyone.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• Participants will be eligible if:
• • 1. are aged 50 to 80
• • 2. have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey
• • 3. currently smoke or formerly smoked cigarettes
• • 4. have no documented history of lung cancer
• • 5. have no documented history of lung cancer screening in the 24 months prior to study enrollment
• • 6. have completed at least one primary care visit at Penn Medicine in the 3 years prior to study enrollment.
• Exclusion criteria:
• • Participants who do not meet inclusion criteria will not be eligible.